![Mike E. Pape](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mike E. Pape
President at Orchard Venture Partners
Mike E. Pape active positions
Companies | Position | Start | End |
---|---|---|---|
Orchard Venture Partners
![]() Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners (Orchard Venture Partners) is a venture capital subsidiary of Orchard Capital Management LLC founded in 2004. The firm is headquartered in Illinois. | Chief Investment Officer | 2004-12-31 | - |
Private Equity Investor | 2004-12-31 | - | |
President | 2004-12-31 | - | |
Apjohn Ventures LLC
![]() Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Consultant / Advisor | - | - |
Michigan Biosciences Industry Association
![]() Michigan Biosciences Industry Association Miscellaneous Commercial ServicesCommercial Services The Michigan Biosciences Industry Association is an official bio-industry association that serves various sectors such as pharmaceutical, medical device, ag-bio, r&d, health IT, and life science logistics. The company is based in Ann Arbor, MI. The association provides cost-savings on business essentials, industry connections and networking, talent support, advocacy, and more. The CEO of the company is Stephen Rapundalo. | Director/Board Member | - | - |
Career history of Mike E. Pape
Former positions of Mike E. Pape
Companies | Position | Start | End |
---|---|---|---|
Base4 Biotechnology, Inc.
![]() Base4 Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Nymirum, Inc. is a biotechnology company that aims to unlock the potential of RNA with small molecules to advance transformative medicine. The company is based in Ann Arbor, MI. The company's subsidiary, Base4 Biotechnology, is developing RNA-modulating small molecule drugs using their next-generation structure-based RNA platform. Nymirum was founded in 2009 by Mike E. Pape, Joshua Paul Fairbank, Hashim M. Al-Hashimi, and Andrew C. Stelzer. | Chief Executive Officer | 2011-06-14 | - |
Chief Tech/Sci/R&D Officer | 2011-06-14 | 2012-11-27 | |
Founder | 2011-06-14 | - | |
Parke-Davis Pharmaceuticals Ltd. | Corporate Officer/Principal | - | - |
SIERRA ONCOLOGY, INC. | Director/Board Member | - | - |
AKEBIA THERAPEUTICS, INC. | Founder | 2007-02-26 | - |
Corporate Officer/Principal | 2007-02-26 | 2013-06-13 | |
ESPERION THERAPEUTICS, INC. | Founder | 1998-04-30 | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Mike E. Pape
Purdue University | Doctorate Degree |
University of Michigan | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Statistics
International
United States | 14 |
Operational
Corporate Officer/Principal | 4 |
Founder | 3 |
Director/Board Member | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 4 |
Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
PFIZER, INC. | Health Technology |
ESPERION THERAPEUTICS, INC. | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
Private companies | 7 |
---|---|
The Upjohn Co. | Health Technology |
Sierra Oncology, Inc.
![]() Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Base4 Biotechnology, Inc.
![]() Base4 Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Nymirum, Inc. is a biotechnology company that aims to unlock the potential of RNA with small molecules to advance transformative medicine. The company is based in Ann Arbor, MI. The company's subsidiary, Base4 Biotechnology, is developing RNA-modulating small molecule drugs using their next-generation structure-based RNA platform. Nymirum was founded in 2009 by Mike E. Pape, Joshua Paul Fairbank, Hashim M. Al-Hashimi, and Andrew C. Stelzer. | Health Technology |
Apjohn Ventures LLC
![]() Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Finance |
Orchard Venture Partners
![]() Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners (Orchard Venture Partners) is a venture capital subsidiary of Orchard Capital Management LLC founded in 2004. The firm is headquartered in Illinois. | Finance |
Michigan Biosciences Industry Association
![]() Michigan Biosciences Industry Association Miscellaneous Commercial ServicesCommercial Services The Michigan Biosciences Industry Association is an official bio-industry association that serves various sectors such as pharmaceutical, medical device, ag-bio, r&d, health IT, and life science logistics. The company is based in Ann Arbor, MI. The association provides cost-savings on business essentials, industry connections and networking, talent support, advocacy, and more. The CEO of the company is Stephen Rapundalo. | Commercial Services |
Parke-Davis Pharmaceuticals Ltd. |
- Stock Market
- Insiders
- Mike E. Pape
- Experience